Streetbeat News

Revenues

DXLG

Destination XL (DXLG) reported a decrease in total sales to $102.4M during the 9-week holiday sales period ended December 31, 2022, compared to $111.7M in the previous year. The company experienced a comparable sales decline of 8.7%, with a 7.6% decrease in store sales and a 10.9% decrease in direct business sales.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:28 pm

LABP

Landos Biopharma, Inc. (NASDAQ:LABP) announced that six abstracts on immunometabolism for autoimmune diseases will be presented at the ECCO congress in February 2024. The data includes studies on novel agonists NX-13 and LABP-69, with NX-13 currently in a Phase 2 trial for ulcerative colitis. Topline results are expected in Q4 2024.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:26 pm

KIDS

OrthoPediatrics Corp. (NASDAQ:KIDS) reported preliminary unaudited Q4 2023 revenue of $37.6M, slightly below the $37.77M estimate, and FY23 revenue of $148.7M, just shy of the $148.88M estimate. The company experienced a 21% growth in Q4 and 22% growth for FY23 compared to the previous year. For FY24, OrthoPediatrics forecasts revenue between $197M-$200M, significantly above the $177.7M estimate, including contributions from the recent Boston O&P acquisition. The acquisition is expected to be accretive to adjusted EBITDA in 2024 and to revenue growth in 2025. OrthoPediatrics has entered into a new credit agreement with MidCap Financial for up to $80M and drew an initial $10M from the term loan in advance of the acquisition.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:23 pm

BT

BT Group's tech incubation unit, Etc., plans to convert traditional broadband street cabinets into EV charging stations in the U.K. The first conversion will take place in East Lothian, Scotland, with technical trials across 60,000 cabinets to address the shortage of public EV charging points. The U.K. government aims to increase charging points to 300,000 by 2030, and BT Group's initiative could help overcome the infrastructure barrier deterring potential EV buyers. The project will assess technical, commercial, and operational factors and has been recognized with an Innovation Honoree award at CES for 2024.

Portfolio Pulse from Benzinga Neuro

January 08, 2024 | 1:22 pm

KIDS

OrthoPediatrics Corp. (NASDAQ:KIDS) has acquired Boston Orthotics & Prosthetics for $22M in cash. The acquisition expands OrthoPediatrics' Specialty Bracing division and its presence in the pediatric orthopedic specialty bracing market. To finance the acquisition and future business needs, OrthoPediatrics closed an $80M debt financing deal with MidCap Financial, replacing a prior $50M credit line. Boston O&P, with a history of profitability and approximately $25M in annual revenue, brings a portfolio of advanced bracing technologies and maintains 26 clinics across the U.S. The acquisition aims to support the continuum of care for pediatric orthopedic patients and address unmet needs in non-surgical orthopedic treatment markets.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:20 pm

BLFS

BioLife Solutions announced preliminary FY23 revenue of $143.3 million, which is slightly below the estimated $144.37 million.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:20 pm

RIGL

Rigel Pharmaceuticals reported preliminary Q4 revenue of approximately $35.7 million, surpassing the estimated $29.78 million.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:18 pm

OSA

ProSomnus, Inc. (NASDAQ:OSA) has welcomed UnitedHealthcare's updated medical policy for Obstructive and Central Sleep Apnea, which now includes oral appliance therapy (OAT) as a prerequisite for Implantable Hypoglossal Nerve Stimulation in adult patients. The policy change, effective March 1, 2024, recognizes the effectiveness of OAT devices like ProSomnus's Precision OAT in treating sleep apnea. Recent studies and patient data support the safety, effectiveness, and patient satisfaction with modern OAT devices, with high success rates reported in clinical trials and follow-ups.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:17 pm

BROS

Dutch Bros Inc. expanded significantly in Q4 2023, opening 37 new shops, with 32 being company-operated. Throughout 2023, they opened 159 new shops, 146 of which were company-operated. The company anticipates opening an additional 150-165 shops in FY24.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:15 pm

NVRI

Harsco Environmental, a division of Enviri Corporation (NYSE:NVRI), has renewed a multi-year services contract with Bahrain's SULB Company. This marks the third consecutive renewal since 2012, emphasizing the trust and partnership between the two companies. The 5-year contract includes slag and scrap management, product handling, yard management, briquetting services, and slag processing. The renewal, effective from Jan. 1, 2024, showcases Harsco's commitment to quality, safety, and sustainability.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:14 pm